- Flu, COVID Vaccination Rates Remain Low as Winter Nears
- ’10 Americas:’ Health Disparities Mean Life Expectancy Varies Across U.S.
- Short-Term Hormone Therapy for Menopause Won’t Harm Women’s Brains
- Could a Vitamin Be Effective Treatment for COPD?
- Woman Receives World’s First Robotic Double-Lung Transplant
- Flavored Vapes Behind Big Surge in U.S. E-Cigarette Sales
- Reading Beyond Headline Rare For Most on Social Media, Study Finds
- Meds Like Ozempic Are Causing Folks to Waste More Food
- Fibroids, Endometriosis Linked to Shorter Life Spans
- E. Coli Fears Spur Recall of 167,000 Pounds of Ground Beef
Reading, Puzzles May Delay Alzheimer’s by 5 Years: Study
An active mind in old age may delay Alzheimer’s disease by up to five years, a new study suggests.
Activities like reading, writing letters, playing cards or doing puzzles may prolong brain health even for those in their 80s, researchers say.
“The key element is that you’re processing information,” said lead researcher Robert Wilson, a professor in the neurological sciences department at Rush University Medical Center, in Chicago.
“Reading is certainly important, but anything that stimulates the mind and is challenging to you intellectually can be helpful,” he said.
Wilson cautioned that this study can’t prove that being mentally active delays dementia, but it “suggests that reading and various cognitive activities may be helpful.”
Although other studies have shown that an active mind delays dementia, this study put a real-world timeframe on the delay.
“There are already estimates that a five-year delay in the onset of this disease could reduce its impact by 40% in the population,” he said.
For the study, Wilson’s team collected data on nearly 2,000 people with an average age of 80 who did not have dementia at the start of the study.
Over seven years, participants were given several mental acuity, or cognitive, tests.
At the start, participants were asked how often they read books and how often they played games like checkers, board games, cards or puzzles in the past year. Participants were also asked about cognitive activity in childhood, adulthood and middle age.
Over the follow-up period, 457 people with an average age of 89 developed Alzheimer’s dementia. Those who had the highest levels of mental activity developed dementia at 94. Those with the lowest levels developed dementia at 89, the researchers found.
Wilson’s group also studied the brains of 695 people who died during the study. They looked for markers of Alzheimer’s like amyloid and tau deposits and tangles, but no association between mental activity and markers of Alzheimer’s disease or other disorders in the brain was found.
Wilson noted that “keeping mentally active is not a pill to stop the underlying plaques and tangles” linked with Alzheimer’s disease. The buildup of amyloid protein plaques in the brain, as well as “tangles” of another protein, tau, are hallmarks of the illness.
Although there are no effective treatments or cures for Alzheimer’s, Wilson and another expert, Dr. Sam Gandy of New York City, said the study adds to evidence that lifestyle changes are one way to help ward off dementia.
“This fits beautifully with decades of basic science and provides the first detailed ‘prescription’ for cognitive activity that doctors can offer to their patients and to the public at large,” said Gandy. He is associate director of the Mount Sinai Alzheimer’s Disease Research Center and a professor of neurology and psychiatry at the Icahn School of Medicine at Mount Sinai.
“We have had three sessions of 30 minutes each per week of brisk walking or weight training for a while. Now we can add this cognitive activity prescription to our repertoire,” Gandy said.
Wilson added, “Changing lifestyles to be more conducive to having a healthy brain can have an enormous impact on your risk for this disease.”
The report was funded by the U.S. National Institute on Aging, and published online July 14 in the journal Neurology.
More information
For more on a healthy brain, head to the Alzheimer’s Association.
SOURCES: Robert Wilson, PhD, professor, department of neurological sciences, Rush University Medical Center, Chicago; Sam Gandy, MD, PhD, associate director, Mount Sinai Alzheimer’s Disease Research Center, and professor of neurology and psychiatry, Icahn School of Medicine at Mount Sinai, New York City; Neurology, July 14, 2021, online
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.